Comparison - PLUR - NASDAQ

Weiss Ratings	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Rating	D
Reward Index	Very Weak
Risk Index	Weak
Risk Grade	D
Reward Grade	E

Rating Factors	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Dividend Index	--
Growth Index	Good
Efficiency Index	Very Weak
Solvency Index	Fair
Total Return Index	Weak
Volatility Index	Weak

Beta / Standard Deviation	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Beta	1.09

Price History	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
7-Day Total Return	0.09%
30-Day Total Return	4.98%
60-Day Total Return	3.71%
90-Day Total Return	3.60%
Year to Date Total Return	9.10%
1-Year Total Return	-37.51%
2-Year Total Return	-28.84%
3-Year Total Return	-71.61%
5-Year Total Return	-81.07%
52-Week High % Change	-43.76%
52-Week Low % Change	16.07%

Price	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
52-Week High Price	$8.40
52-Week Low Price	$4.07
52-Week Low Price (Date)	Dec 31, 2024
52-Week High Price (Date)	Mar 26, 2024

Valuation	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Market Cap	33.06M
Enterprise Value	46.15M
Price/Earnings (TTM)	--
Earnings Per Share (TTM)	-3.69
Earnings Per Share Growth	-21.41%
Price/Earnings To Growth	--
Price/Sales (TTM)	38.72
Price/Book (Q)	-3.27
Enterprise Value/Revenue (TTM)	68.07
Price	$4.72
Enterprise Value/EBITDA (TTM)	-2.15
Enterprise Value/EBIT	-2.12
Market Cap Category	Nano Cap

Dividends and Shares	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Shares Outstanding	5.55M
Dividend Yield	--
Div. Per Share (Most Recent)	--
Dividend Per Share (TTM)	--
Payout Ratio (TTM)	--
Dividend Per Share (Most Recent)	--

Company Info	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Phone Number	972 74 710 8600
Address	--
Website	www.pluri-biotech.com
Country	Israel
Year Founded	2001

Profitability	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Operating Margin (TTM)	-3,203.98%
Profit Margin	-2,929.20%

Management Effectiveness	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Return on Assets	-37.49%
Return on Equity	--

Income Statement	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Revenue (TTM)	678.00K
Total Revenue (TTM)	678.00K
Revenue Per Share	$0.12
Gross Profit (TTM)	474.00K
EBITDA (TTM)	-21.47M
EBIT (TTM)	-21.72M
Net Income (TTM)	-19.86M
Net Income Avl. to Common (TTM)	-19.86M
Total Revenue Growth (Q YOY)	76.19%
Earnings Growth (Q YOY)	37.73%
EPS Diluted (TTM)	-3.69
EPS Diluted Growth (Q YOY)	43.67%

Balance Sheet	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash and Short-Term Inv. (Q)	21.31M
Cash Per Share (Q)	$3.84
Total Current Assets (Q)	22.37M
Total Preferred Equity (Q)	--
Total Equity (Q)	-2.92M
Current Ratio (Q)	5.038
Book Value Per Share (Q)	-$1.44
Total Assets (Q)	30.86M
Total Current Liabilities (Q)	4.44M
Total Debt (Q)	29.30M
Total Liabilities (Q)	33.78M
Total Common Equity (Q)	-8.03M

Cash Flow	PLUR - NASDAQ	Click to Compare	Click to Compare	Click to Compare
Cash from Investing (TTM)	10.09M
Cash from Financing (TTM)	8.84M
Net Change in Cash (TTM)	1.80M
Levered Free Cash Flow (TTM)	-11.84M
Cash from Operations (TTM)	-17.21M